Is Becton, Dickinson and Company overvalued?

Becton, Dickinson and Company (BDX) looks overvalued — trading about 30% above its fair value.

Overvalued

Price

$183.82

Fair value

$128.63

Current P/E

31.5

Normal P/E

22.1

Market cap

$50.65B

Dividend yield

2.2%

Return on equity

3.8%

Sector

Healthcare

Fair value compares BDX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks